查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球單細胞組學市場 2023-2030
市場調查報告書
商品編碼
1380386

全球單細胞組學市場 2023-2030

Global Single-Cell Omics Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

預計全球單細胞組學市場在預測期內（2023-2030）將以 18.2% 的CAGR成長。許多癌症中心和全球製藥公司擴大採用 Tapestri 平台進行轉化研究和臨床開發，證明了單細胞多組學的必要性。單細胞組學提供了行動解決方案，因為它們可以透過大多數電子設備輕鬆存取。單細胞組學是一個快速發展的領域，在廣泛的生物醫學研究領域中得到應用。隨著該技術變得更加容易獲得和負擔得起，它正在被全球研究人員採用。

細分市場前景

全球單細胞組學市場按產品類型、應用和最終用戶細分。根據產品類型，市場細分為單細胞基因組學、單細胞轉錄組學、單細胞蛋白質組學和單細胞代謝組學。根據應用，市場細分為腫瘤學、細胞生物學、神經學、免疫學等。根據最終用戶，市場細分為製藥和生物技術公司、學術和研究組織以及醫院和診斷實驗室。在最終用戶中，由於私營和政府學術和研究組織目前正在進行的研究計畫數量激增，預計學術和研究組織細分市場將佔據相當大的市場佔有率。

預計腫瘤學細分市場將在全球單細胞組學市場中佔據相當大的佔有率

其中，腫瘤學細分市場預計將在全球單細胞組學市場中佔據相當大的佔有率。這種細分成長歸因於多種因素，例如癌症患病率的增加以及單細胞分析在研究癌症進展中的應用不斷增加，預計將推動對組學技術在了解癌症細胞生物學方面的需求。例如，2023年6月，Owkin、Nanostring和全球領先的癌症研究機構匹茲堡大學、Gustave Roussy、洛桑大學醫院、Uniklinikum Erlangen/Friedrich-Alexander-Universitat Erlangen-Nurnberg和Charite - Universitatsmedizin Berlin正在推出MOSAIC（MultiOmic空間圖譜）在美國臨床腫瘤學會年會上。 MOSAIC 是一個耗資 5000 萬美元的里程碑式項目，旨在透過使用空間組學徹底改變癌症研究，空間組學是一組尖端技術，可提供有關腫瘤結構的前所未有的資訊。

區域展望

全球單細胞組學市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國） 、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於透過單細胞組學進行智慧學習的採用越來越多，預計亞太地區將在全球市場中佔據顯著佔有率。

北美地區預計全球單細胞組學市場將以顯著的複合CAGR成長

在所有地區中，北美地區預計在預測期內將以相當大的CAGR成長。區域成長歸因於醫療基礎設施的改善以及市場參與者為更好地研究和產品開發而增加的策略性舉措。例如，2023 年 4 月，高通量單細胞 DNA 和多組學分析領域的先驅 Mission Bio, Inc. 宣布已與 Fulgent Genetics 達成協議，Fulgent Genetics 是一家技術型公司，擁有良好的建立臨床診斷業務和治療開發業務。 Fulgent Genetics 現在能夠在Tapestri 平台上透過其完全可客製化的服務菜單提供單細胞多組學，包括全基因組、全外顯子組、RNA 定序、腫瘤分析、甲基化測序、液體活體組織切片、單細胞測序、空間定序生物學和病理學服務，以滿足其不斷成長的製藥客戶需求。此外，Fulgent Genetics 將評估 Tapestri 平台在臨床開發中的應用，以簡化藥物開發和核准流程。

此外，該地區不斷增加的投資活動和政府措施也正在推動市場。例如，2023 年 11 月，德州 A&M 大學系統獲得了美國國立衛生研究院 (NIH) 的 119 萬美元撥款，用於多學科合作，研究基因組學、營養和健康之間的複雜聯繫。了解這些關聯將有助於癌症和其他疾病的診斷和治療。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • 10x Genomics, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Bio Rad Laboratories, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Mission Bio, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按產品類型分類的全球單細胞組學市場
    • 單細胞基因體學
    • 單細胞轉錄組學
    • 單細胞蛋白質體學
    • 單細胞代謝組學
  • 全球單細胞組學市場（按應用）
    • 腫瘤學
    • 細胞生物學
    • 神經病學
    • 免疫學
    • 其他（微生物學）
  • 按最終用戶分類的全球單細胞組學市場
    • 製藥和生物技術公司
    • 學術和研究組織
    • 醫院和診斷實驗室

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Becton, Dickinson and Company
  • Berkeley Lights Inc
  • BGI Genomics Co. Ltd
  • Danaher Corp (Cytiva Life Sciences)
  • Dolomite Bio
  • Epicypher Inc.
  • Fluidigm Corp
  • Illimina, Inc
  • Miltenyi Biotec B.V. & CO.
  • Nanostring Technologies, Inc
  • Olink Holding AB (Olink Proteomics)
  • Parse Bioscience
  • Qiagen N.V.
  • Takara Holdings Inc. Takara Bio Group
  • Thermo Fisher Scientific, Inc.
Product Code: OMR2027795

Title: Global Single-cell omics Market Size, Share & Trends Analysis Report by product Type (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, and Single-Cell Metabolomics), by Application (Oncology, Cell Biology, Neurology, Immunology, and Other) and by End User (Pharmaceutical & Biotechnology Companies, Academic and Research Organizations and Hospital and Diagnostic Laboratories),Forecast Period (2023-2030).

The global Single-cell omics market is anticipated to grow at a CAGR of 18.2% during the Forecast Period (2023-2030). The increasing adoption of the Tapestri Platform for translational research and clinical development by many cancer centers and global pharma companies demonstrates the necessity of single-cell multi-omics. Single-cell omics provides mobility solutions as they are easily accessible via most electronic devices. Single-cell omics is a rapidly growing field with applications in a wide range of biomedical research areas. As the technology becomes more accessible and affordable, it is being adopted by researchers globally.

Segmental Outlook

The global Single-cell omics market is segmented on the product type, application, and end user. Based on the product type, the market is sub-segmented into single-cell genomics, single-cell transcriptomics, single-cell proteomics, and single-cell metabolomics. Based on application, the market is sub-segmented into oncology, cell biology, neurology, immunology and other. And based on the end user, the market is sub-segmented into pharmaceutical & biotechnology companies, academic and research organizations and hospital and diagnostic laboratories. among the end user, the academic and research organizations sub-segment is anticipated to hold a considerable share of the market, owing to the spike in the number of research projects that are currently underway at private and government academic and research organizations.

The Oncology Sub-Segment is Anticipated to Hold a Considerable Share of the Global Single-cell omics Market

Among the application, the Oncology sub-segment is expected to hold a considerable share of the global Single-cell omics market. This segmental growth is attributed to several factor such as, increasing prevalence of cancer and rising applications of single-cell analysis in studying cancer progression is projected to fuel the demand for omics technology in understanding the cell biology of cancer. For instance, In June 2023, Owkin, Nanostring and world-leading cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universitat Erlangen-Nurnberg, and Charite - Universitatsmedizin Berlin are launching MOSAIC (Multi Omic Spatial Atlas In Cancer) at the American Society of Clinical Oncology's annual meeting. MOSAIC is a landmark $50 million project to revolutionize cancer research through the use of spatial omics, a set of cutting-edge technologies that offer unprecedented information on the structure of tumors.

Regional Outlook

The global Single-cell omics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to growing adoption of smart learning through Single-cell omics.

The North America Region is Expected to Grow at a Significant CAGR in the Global Single-cell omics Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to improving medical infrastructure and increasing strategic initiatives by market player for better research and product development in the regions. For instance, in April 2023, Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced that it has entered into an agreement with Fulgent Genetics, a technology-based company with a well-established clinical diagnostic business and a therapeutic development business. Fulgent Genetics is now able to offer single-cell multi-omics on the Tapestri Platform on its fully customizable menu of services, including whole genome, whole exome, RNA sequencing, tumor profiling, methylation sequencing, liquid biopsy, single-cell sequencing, spatial biology, and pathology services to support its growing pharma client demands. Additionally, Fulgent Genetics will evaluate the Tapestri Platform for applications in clinical development to streamline the drug development and approval process.

Also, increasing investing activities and government initiatives in the region, are also driving the market. For instance, in November 2023, The Texas A&M University System has received a $1.19 million grant from the National Institutes of Health (NIH) for a multidisciplinary collaboration to study the intricate connections between genomics, nutrition and health. Understanding these connections will help in the diagnosis and treatment of cancer and other diseases.

Market Players Outlook

The major companies serving the Single-cell omics market include: Becton, Dickinson and Company, Berkeley Lights Inc, BGI Genomics Co. Ltd, Danaher Corp, Dolomite Bio, Epicypher Inc., Fluidigm Corp, Illimina, Inc, Miltenyi Biotec B.V. & CO., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In August 2023, Scale Biosciences, Inc. announced an expansion of their product portfolio to enable a broader range of single cell omics experiments and unlock new translational research applications. New products include the ScaleBio Single Cell Methylation Kit, ScaleBio Single Cell CRISPR Guide Enrichment Kit, Scale-plex Kit, and additional capabilities for the company's existing ScaleBio Single Cell RNA Sequencing Kit to facilitate more diverse experimental designs and broader use of translational samples leveraging innovative, scalable, and accessible tools to democratize single cell omics across research applications without the need for additional instrumentation.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Single-cell omics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. 10x Genomics, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bio Rad Laboratories, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Mission Bio, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Single-cell Omics Market by Product Type
    • 4.1.1. Single-Cell Genomics
    • 4.1.2. Single-Cell Transcriptomics
    • 4.1.3. Single-Cell Proteomics
    • 4.1.4. Single-Cell Metabolomics
  • 4.2. Global Single-cell Omics Market by Application
    • 4.2.1. Oncology
    • 4.2.2. Cell Biology
    • 4.2.3. Neurology
    • 4.2.4. Immunology
    • 4.2.5. other (Microbiology)
  • 4.3. Global Single-cell Omics Market by End-User
    • 4.3.1. Pharma and biotech companies
    • 4.3.2. Academic and Research Organizations
    • 4.3.3. Hospital and Diagnostic Laboratories

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Becton, Dickinson and Company
  • 6.2. Berkeley Lights Inc
  • 6.3. BGI Genomics Co. Ltd
  • 6.4. Danaher Corp (Cytiva Life Sciences)
  • 6.5. Dolomite Bio
  • 6.6. Epicypher Inc.
  • 6.7. Fluidigm Corp
  • 6.8. Illimina, Inc
  • 6.9. Miltenyi Biotec B.V. & CO.
  • 6.10. Nanostring Technologies, Inc
  • 6.11. Olink Holding AB (Olink Proteomics)
  • 6.12. Parse Bioscience
  • 6.13. Qiagen N.V.
  • 6.14. Takara Holdings Inc. Takara Bio Group
  • 6.15. Thermo Fisher Scientific, Inc.

LIST OF TABLES

  • 1. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL GENOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL TRANSCRIPTOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PROTEOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL METABOLOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ONCOLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 8. GLOBAL CELL BIOLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 9. GLOBAL NEUROLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 10. GLOBAL IMMUNOLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 11. GLOBAL OTHER APPLICATIONS IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 12. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 13. GLOBAL SINGLE-CELL OMICS FOR PHARMA AND BIOTECH COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL SINGLE-CELL OMICS FOR ACADEMIC AND RESEARCH ORGANIZATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL SINGLE-CELL OMICS FOR HOSPITAL AND DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 21. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 23. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 27. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY PRODUCT TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL GENOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL TRANSCRIPTOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PROTEOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL METABOLOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 7. GLOBAL ONCOLOGY SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL CELL BIOLOGY REALITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL NEUROLOGY SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL IMMUNOLOGY SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL OTHER APPLICATIONS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 13. GLOBAL SINGLE-CELL OMICS FOR PHARMA AND BIOTECH COMPANIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL SINGLE-CELL OMICS FOR ACADEMIC AND RESEARCH ORGANIZATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL SINGLE-CELL OMICS FOR HOSPITAL AND DIAGNOSTIC LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. US SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CANADA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. UK SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. FRANCE SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. GERMANY SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. ITALY SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SPAIN SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF EUROPE SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. INDIA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. CHINA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. JAPAN SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. SOUTH KOREA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF ASIA-PACIFIC SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)